Shots: The P-III study involves assessing of Lyrica (pregabalin, bid, 5mg/10mg) vs PBO in 219 patients in a ratio (1:1:1) with PGTC seizures aged 5 to 65 yrs. across 21 […]readmore
Tags : Primary Generalized Tonic-Clonic Seizures
Latest Posts
Categories
Related Topics
AbbVie
Acceptance
Acquire
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Boehringer Ingelheim
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Lilly
Merck
Novartis
P-III
patients
Pfizer
receives
Regeneron
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
Treat
Treatment
US